Ovation Science enhances Skinvisible partnership for obesity treatments Sep 18, 2025 05:00AM
Ovation Science and Skinvisible Pharmaceuticals Enhance Their Strategic Partnership in the Obesity Market with Innovative Cannabinoid Delivery Technology with New Developments and Patent Protection Sep 18, 2025 05:00AM
Skinvisible Reports Licensee Success in Netherton Syndrome Clinical Studies Jan 23, 2025 05:30AM
Skinvisible Announces Article Highlighting Its Proprietary Transdermal Obesity Formulation Development Oct 3, 2024 06:30AM
Promising Data on Transdermal Obesity Formulations Announced by Skinvisible Jul 11, 2024 12:15PM


Jul 9, 2024 09:00AM Skinvisible Unveils Promising Data on Transdermal Obesity Formulations
Jun 24, 2024 09:03AM Skinvisible Expands Obesity Patent Application for Transdermal Delivery
Jun 24, 2024 09:03AM Skinvisible Expands Obesity Patent Application for Transdermal Delivery